Kevin Doody's most recent trade in NAYA Biosciences was a trade of 9,088 Stock Option done . Disclosure was reported to the exchange on Jan. 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NAYA Biosciences | Kevin Doody | Director, Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 9,088 | 9,088 | - | - | Stock Option | |
| NAYA Biosciences | Kevin Doody | Director, Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 7,480 | 177,306 | - | 0 | Common Stock |